City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Ryotaro Nakamura, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 17050 ClinicalTrials.gov Number: NCT02406651

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  A Phase IIa Study of Recombinant Human Interleukin-22 IgG2-Fc (F-652) in Combination with Systemic Corticosteroids for the Treatment of Newly Diagnosed Grade II-IV Lower Gastrointestinal Acute Graft-versus-Host Disease (aGVHD) in Hematopoietic Stem Cell Transplantation Recipients

COH Protocol Number: 15447

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Institutional

Title:  Mount Sinai Acute Graft-versus-Host Disease International Consortium (MAGIC): A Database and Biorepository

COH Protocol Number: 13377 ClinicalTrials.gov Number: NCT02016781

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: NCI Approved External Peer Review

Title:  BMT CTN 1102: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Age 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.